Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

"We need more": UN joins criticism of G7 vaccine pledge

06/11/2021 | 02:37am EDT

* G7 to pledge 1 billion vaccine doses

* Campaigners say G7 too slow, lacks ambition

* Britain to give 100 million doses

* UK says some countries using vaccines to exert influence (Adds UN comment)

CARBIS BAY, England, June 11 (Reuters) - A Group of Seven plan to donate 1 billion COVID-19 vaccine doses to poorer countries lacks ambition, is far too slow and shows Western leaders are not yet on top of tackling the worst public health crisis in a century, campaigners said on Friday.

While the head of the United Nations welcomed the move, even he said more was needed. Antonio Guterres warned that if people in developing countries were not inoculated quickly, the virus could mutate further and become resistant to the new vaccines.

"We need more than that," he said of the G7 plan. "We need a global vaccination plan. We need to act with a logic, with a sense of urgency, and with the priorities of a war economy, and we are still far from getting that."

U.S. President Joe Biden and British Prime Minister Boris Johnson had used the G7 summit in England to announce the donation of 500 million and 100 million vaccines respectively for the world's poorest nations.

Canada is expected to commit to sharing up to 100 million doses and other pledges may follow after Johnson urged G7 leaders to help inoculate the world's nearly 8 billion people against the coronavirus by the end of next year.

But health and anti-poverty campaigners said that, while donations were a step in the right direction, Western leaders had failed to grasp that exceptional efforts were needed to beat the virus. Help with distribution was also necessary, they said.

Former British prime minister Gordon Brown, who has been pushing for richer countries to share more of the cost of vaccinating developing countries, said the G7 pledges were more akin to "passing round the begging bowl" than a real solution.

"It's a catastrophic failure if we can't go away in the next week or two ... with a plan that actually rids the world of COVID now we've got a vaccine," he told Reuters.

Alex Harris at Wellcome, a London-based science and health charitable foundation, challenged the G7 to show the political leadership the crisis demanded.

"What the world needs is vaccines now, not later this year," he said. "We urge G7 leaders to raise their ambition."

'FAILURE'

COVID-19 has ripped through the global economy, with infections reported in more than 210 countries and territories since the first cases were identified in China in December 2019.

The race to end a pandemic that has killed around 3.9 million people and sown social and economic destruction will feature prominently at the three-day summit which began on Friday in the English seaside resort of Carbis Bay.

British foreign minister Dominic Raab warned that other countries were using vaccines as diplomatic tools to secure influence. Britain and the United States said their donations would come with no strings attached.

Vaccination efforts so far are heavily correlated with wealth: the United States, Europe, Israel and Bahrain are far ahead of other countries. A total of 2.2 billion people have been vaccinated according to Johns Hopkins University data.

As most people need two vaccine doses, and possibly booster shots to tackle emerging variants, charity Oxfam said the world would need 11 billion doses to end the pandemic.

"If the best G7 leaders can manage is to donate 1 billion vaccine doses then this summit will have been a failure," Oxfam's health policy manager Anna Marriott said.

Oxfam also called on G7 leaders to support a waiver on the intellectual property behind the vaccines.

French President Emmanuel Macron has said intellectual property rights should not hinder access to vaccines during a pandemic, appearing to back Biden on the subject.

VACCINE OWNERSHIP?

But the pharmaceutical industry has opposed it, saying it would stifle innovation and do little to increase supplies. Britain, which backed Oxford-AstraZeneca's not-for-profit shot, has said a patent waiver is not necessary.

Of the 100 million British shots, 80 million will go to the COVAX programme led by the World Health Organization (WHO) and the rest will be shared bilaterally with countries in need.

Johnson echoed Biden in calling on his fellow leaders to make similar pledges and for pharmaceutical companies to adopt the not-for-profit model during the pandemic. The U.S. donation of Pfizer shots will be supplied at cost.

The British doses will be drawn from the stock it has already procured for its domestic programme, and will come from suppliers Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson's Janssen, Moderna and others.

(Additional reporting by Alistair Smout in London, Michelle Nichols in New York and David Ljunggren in Ottawa; Editing by Guy Faulconbridge, Alex Richardson, Emelia Sithole-Matarise and Catherine Evans)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.32% 8414 Delayed Quote.14.46%
BIONTECH SE 5.08% 214.2 Delayed Quote.162.76%
MARRIOTT INTERNATIONAL, INC. -0.99% 141.79 Delayed Quote.7.48%
MODERNA, INC. 2.34% 202.47 Delayed Quote.93.81%
PFIZER, INC. 0.46% 39.48 Delayed Quote.7.25%
All news about ASTRAZENECA PLC
07:22aUNIVERSITY OF CAMBRIDGE : Apollo Therapeutics launches with GBP100m investment; ..
AQ
06:25aEUROPEAN MIDDAY BRIEFING  : Stocks Slip as -2-
DJ
06:05aMARKET CHATTER : South Korea To Give Pfizer's Jab As Second Dose Instead Of Astr..
MT
04:06aASTRAZENECA  : NACI advice to mix vaccines gets varied reaction from AstraZeneca..
AQ
03:58aASTRAZENECA  : Thai Partner Misses COVID-19 Vaccine Delivery Targets
MT
03:04aASTRAZENECA  : S.Korea to mix-and-match COVID-19 vaccine doses for 760,000 peopl..
RE
12:27aEMEA MORNING BRIEFING  : Cautious Post-Fed Action -2-
DJ
12:27aEMEA MORNING BRIEFING  : Cautious Post-Fed Action to Hold Back Shares
DJ
12:18aTaiwan to allow Foxconn's Gou, TSMC to negotiate for vaccines
RE
06/17ASTRAZENECA  : S.Korea to mix-and-match COVID-19 vaccine doses for 760,000 peopl..
RE
More news
Financials (USD)
Sales 2021 30 988 M - -
Net income 2021 4 559 M - -
Net Debt 2021 10 731 M - -
P/E ratio 2021 36,8x
Yield 2021 2,44%
Capitalization 153 B 153 B -
EV / Sales 2021 5,30x
EV / Sales 2022 4,57x
Nbr of Employees 76 100
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 133,03 $
Last Close Price 116,84 $
Spread / Highest target 46,3%
Spread / Average Target 13,9%
Spread / Lowest Target -17,6%
EPS Revisions
Managers and Directors
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC14.46%153 347
JOHNSON & JOHNSON4.98%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.7.25%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.7.23%202 939